These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7691064)
21. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Ramírez F; Mason D Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389 [TBL] [Abstract][Full Text] [Related]
22. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118 [TBL] [Abstract][Full Text] [Related]
23. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871 [TBL] [Abstract][Full Text] [Related]
25. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Ellerman KE; Powers JM; Brostoff SW Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505 [TBL] [Abstract][Full Text] [Related]
26. [Inhibiton of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99]. Sun B; Yang S; Peng HS; Qiao H; Cao JY; Jin LH; Li HL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):106-9. PubMed ID: 17286899 [TBL] [Abstract][Full Text] [Related]
27. Adoptively transferred experimental allergic encephalomyelitis in chimeric rats: identification of transferred cells in the lesions of the central nervous system. Matsumoto Y; Fujiwara M Immunology; 1988 Sep; 65(1):23-9. PubMed ID: 3053424 [TBL] [Abstract][Full Text] [Related]
28. Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. Mannie MD; Rendall SK; Arnold PY; Nardella JP; White GA J Immunol; 1996 Aug; 157(3):1062-70. PubMed ID: 8757610 [TBL] [Abstract][Full Text] [Related]
29. Experimental allergic encephalomyelitis and vaccination-induced resistance in DA rats. Bouwer HG; Hinrichs DJ Cell Immunol; 1997 Jan; 175(1):92-8. PubMed ID: 9015193 [TBL] [Abstract][Full Text] [Related]
30. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. Fritz RB; Chou CH; McFarlin DE J Immunol; 1983 Mar; 130(3):1024-6. PubMed ID: 6185565 [TBL] [Abstract][Full Text] [Related]
31. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan. Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293 [TBL] [Abstract][Full Text] [Related]
32. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. Miura Y; Thoburn CJ; Bright EC; Hess AD Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881 [TBL] [Abstract][Full Text] [Related]
33. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE. Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735 [TBL] [Abstract][Full Text] [Related]
34. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796 [TBL] [Abstract][Full Text] [Related]
35. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis. Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193 [TBL] [Abstract][Full Text] [Related]
36. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. Sobel RA; Blanchette BW; Bhan AK; Colvin RB J Immunol; 1984 May; 132(5):2393-401. PubMed ID: 6371137 [TBL] [Abstract][Full Text] [Related]
37. Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility. Fesel C; Coutinho A J Autoimmun; 2000 Jun; 14(4):319-24. PubMed ID: 10882058 [TBL] [Abstract][Full Text] [Related]
38. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis. Wegmann KW; Hinrichs DJ J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543 [TBL] [Abstract][Full Text] [Related]
39. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease. Welch AM; Holda JH; Swanborg RH J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396 [TBL] [Abstract][Full Text] [Related]
40. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]